Lung transplantation is a viable option for many end-stage lung diseases. In the last decade, there has been a steady growth in the number of qualified patients receiving lung transplants in the United States and around the world. Nationally, over 2000 lung transplants are being performed each year.

Candidates for lung transplantation have end-stage lung disease that may be caused by one of the following conditions:

• Alpha-1 antitrypsin deficiency
• Chronic obstructive pulmonary disease (COPD)
• Cystic fibrosis
• Emphysema
• Lung disease due to previous cancer treatments
• Occupational lung disease
• Pulmonary fibrosis
• Pulmonary hypertension
• Sarcoidosis - a condition that causes lumps or nodules to form in your lungs, lymph nodes and other parts of your body.
• Scleroderma - autoimmune disease that causes inflammation in the skin and other areas of the body

Ochsner is a Medicare-approved lung transplant program, and we accept most insurance carriers.

The Ochsner Transplant Institute provides consistent follow-up information to all referring physicians via written correspondence. You’ll be kept abreast of initial clinic visits, surgery, hospital discharge and routine follow-up visits to the clinic. After surgery, our team continues to monitor for transplant-related complications and regulates maintenance immunosuppression.

To refer a patient to one of the best lung transplant hospitals in the country, please:

1. Fill out this this referral document.
2. Either fax the referral document over to our department (fax number 504-842-6627) or email referrals to ReferLungTransplant@ochsner.org.
3. You can also call our 24-hour Referral Hotline, 1-800-643-1635.

Please contact our department one of the following ways:

1. Telephone: 504-842-3925
2. Fax: 504-842-6627
3. Email: ReferLungTransplant@ochsner.org